All potential transplant candidates undergo medical and psychosocial evaluations, which are crucial in determining whether they can get a transplant. The latter are meant to ensure that a patient has adequate social support ...
Mar 15, 2023
0
2
A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients. The result is in striking contrast to a ...
Researchers who studied more than 300 pediatric patients receiving heart transplants over the past 36 years at the University of Florida have documented how advances in technology, technique, and patient management have improved ...
Feb 22, 2023
0
4
For patients with pretreated relapsed and refractory multiple myeloma, idecabtagene vicleucel (ide-cel), a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, prolongs progression-free survival and ...
Feb 10, 2023
0
2
In non-cirrhotic liver diseases, organ transplantation in two steps, especially with a living donation, is a safe therapy option for donors and recipients. This is the conclusion of a case series evaluated by surgeons from ...
Jan 31, 2023
0
2
An academic medical center in Charleston, South Carolina, has been able to significantly improve access to kidney transplants for African Americans by streamlining and standardizing the evaluation process, improving patient ...
Jan 26, 2023
0
2
With heart disease the No. 1 killer in the United States, heart transplants hit record highs in 2022.
Jan 20, 2023
0
11
Treating patients who possess transplant rejecting antibodies, using best available combinations of oral drugs, does not have an impact on transplant failure rates but it does improve medication adherence and reduce rejection ...
Jan 18, 2023
0
28
For patients undergoing liver transplant (LT), Epstein-Barr virus (EBV) viral load (VL) monitoring may reduce the incidence of posttransplant lymphoproliferative disease (PTLD), according to a study published online Jan. ...
Jan 18, 2023
0
2
Researchers at the University of Colorado Anschutz Medical Campus have discovered a drug combination that may offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain ...
Jan 16, 2023
0
29
